Janney Montgomery Scott LLC raised its stake in Cognex Co. (NASDAQ:CGNX – Free Report) by 35.4% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 25,469 shares of the scientific and technical instruments company’s stock after acquiring an additional 6,656 shares during the period. Janney Montgomery Scott LLC’s holdings in Cognex were worth $913,000 at the end of the most recent quarter.
A number of other institutional investors have also recently modified their holdings of CGNX. Point72 Asset Management L.P. raised its position in shares of Cognex by 122.7% in the 3rd quarter. Point72 Asset Management L.P. now owns 2,834,755 shares of the scientific and technical instruments company’s stock valued at $114,808,000 after buying an additional 1,562,115 shares in the last quarter. Ceredex Value Advisors LLC boosted its holdings in shares of Cognex by 116.0% in the 3rd quarter. Ceredex Value Advisors LLC now owns 789,550 shares of the scientific and technical instruments company’s stock valued at $31,977,000 after purchasing an additional 423,950 shares in the last quarter. Northwest & Ethical Investments L.P. increased its stake in shares of Cognex by 91.5% in the 3rd quarter. Northwest & Ethical Investments L.P. now owns 642,737 shares of the scientific and technical instruments company’s stock valued at $26,031,000 after purchasing an additional 307,018 shares during the last quarter. Disciplined Growth Investors Inc. MN raised its holdings in shares of Cognex by 8.9% during the 3rd quarter. Disciplined Growth Investors Inc. MN now owns 3,751,807 shares of the scientific and technical instruments company’s stock worth $151,948,000 after buying an additional 305,913 shares in the last quarter. Finally, Swedbank AB lifted its position in shares of Cognex by 21.4% during the 3rd quarter. Swedbank AB now owns 1,700,000 shares of the scientific and technical instruments company’s stock worth $68,850,000 after buying an additional 300,000 shares during the last quarter. 88.12% of the stock is currently owned by institutional investors.
Insiders Place Their Bets
In other Cognex news, CTO Joerg Kuechen sold 2,934 shares of the firm’s stock in a transaction on Thursday, December 12th. The shares were sold at an average price of $37.75, for a total value of $110,758.50. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, Director Anthony Sun sold 26,000 shares of the stock in a transaction dated Friday, November 22nd. The stock was sold at an average price of $40.03, for a total transaction of $1,040,780.00. Following the transaction, the director now directly owns 26,608 shares in the company, valued at $1,065,118.24. This trade represents a 49.42 % decrease in their position. The disclosure for this sale can be found here. Company insiders own 1.30% of the company’s stock.
Cognex Stock Up 1.4 %
Wall Street Analyst Weigh In
CGNX has been the topic of a number of research analyst reports. Needham & Company LLC reduced their price target on shares of Cognex from $50.00 to $47.00 and set a “buy” rating on the stock in a research note on Friday, November 1st. Citigroup lowered their price target on shares of Cognex from $44.00 to $42.00 and set a “neutral” rating for the company in a report on Monday, January 13th. Stephens reissued an “overweight” rating and set a $55.00 price objective on shares of Cognex in a report on Thursday, January 2nd. Cantor Fitzgerald raised Cognex to a “strong-buy” rating in a report on Friday, December 20th. Finally, Truist Financial lifted their price target on Cognex from $42.00 to $43.00 and gave the company a “hold” rating in a research note on Thursday, January 16th. One equities research analyst has rated the stock with a sell rating, five have issued a hold rating, six have given a buy rating and one has issued a strong buy rating to the stock. According to MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $47.92.
View Our Latest Analysis on CGNX
Cognex Profile
Cognex Corporation provides machine vision products that capture and analyze visual information to automate manufacturing and distribution tasks worldwide. Its machine vision products are used to automate the manufacturing and tracking of discrete items, including mobile phones, electric vehicle batteries, and e-commerce packages by locating, identifying, inspecting, and measuring them during the manufacturing or distribution process.
Read More
- Five stocks we like better than Cognex
- What is a Dividend Harvesting Strategy and How Can Investors Profit from it?
- 3 Must-Have ETFs Set to Dominate This Quarter
- What is an Earnings Surprise?
- Seeking Stability? These 3 Stocks Offer Strong Potential
- What is the Euro STOXX 50 Index?
- Trade War Bargain Stocks: Top 3 Picks Too Good to Pass Up
Want to see what other hedge funds are holding CGNX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cognex Co. (NASDAQ:CGNX – Free Report).
Receive News & Ratings for Cognex Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cognex and related companies with MarketBeat.com's FREE daily email newsletter.